Pharmerica Corp. v. United States ex rel. Silver
140 S. Ct. 202, 205 L. Ed. 2d 195
CourtSupreme Court of the United States
DecidedOctober 7, 2019
DocketNo. 18-1044
StatusPublished
Cited by1 cases
This text of 140 S. Ct. 202 (Pharmerica Corp. v. United States ex rel. Silver) is published on Counsel Stack Legal Research, covering Supreme Court of the United States primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Bluebook
Pharmerica Corp. v. United States ex rel. Silver, 140 S. Ct. 202, 205 L. Ed. 2d 195 (U.S. 2019).
Opinion
Motion of Pharmaceutical Research and Manufacturers of America, et al. for leave to file a brief as amici curiae granted. Petition for writ of certiorari to the United States Court of Appeals for the Third Circuit denied.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
STURGEON v. PHARMERICA CORPORATION
E.D. Pennsylvania, 2020
Cite This Page — Counsel Stack
Bluebook (online)
140 S. Ct. 202, 205 L. Ed. 2d 195, Counsel Stack Legal Research, https://law.counselstack.com/opinion/pharmerica-corp-v-united-states-ex-rel-silver-scotus-2019.